Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	SIN3B OGT POLE SIN3A EYA3 APP TTF1 CREB3L1 HIRA THRA THRB KMT5B NFE2L1 SUPT6H ATAD2B GRHL3 TAF10 TAF1L CREB3	2.54e-05	739	174	19	GO:0003682
GeneOntologyCellularComponent	postsynaptic specialization	GABRB2 CACNA1C LRFN1 RAPSN PCLO ANKS1B CLSTN1 ERBIN FAM81A RYK SYNGAP1 PRR12 TIAM1 SYT11 PTPRO DAGLA SHISA6	1.40e-06	503	177	17	GO:0099572
GeneOntologyCellularComponent	postsynaptic specialization membrane	GABRB2 CACNA1C LRFN1 RAPSN CLSTN1 RYK TIAM1 PTPRO DAGLA SHISA6	8.62e-06	201	177	10	GO:0099634
GeneOntologyCellularComponent	asymmetric synapse	CACNA1C LRFN1 OGT PCLO ANKS1B CLSTN1 FAM81A RYK SYNGAP1 PRR12 TIAM1 SYT11 PTPRO DAGLA SHISA6	1.41e-05	477	177	15	GO:0032279
GeneOntologyCellularComponent	postsynaptic density	CACNA1C LRFN1 PCLO ANKS1B CLSTN1 FAM81A RYK SYNGAP1 PRR12 TIAM1 SYT11 PTPRO DAGLA SHISA6	3.17e-05	451	177	14	GO:0014069
GeneOntologyCellularComponent	neuron to neuron synapse	CACNA1C LRFN1 OGT PCLO ANKS1B CLSTN1 FAM81A RYK SYNGAP1 PRR12 TIAM1 SYT11 PTPRO DAGLA SHISA6	4.09e-05	523	177	15	GO:0098984
GeneOntologyCellularComponent	postsynapse	GABRB2 CACNA1C LRFN1 OGT RAPSN MYO9B PCLO ANKS1B NBEA APP CLSTN1 ERBIN FAM81A RYK SYNGAP1 PRR12 MET TIAM1 SYT11 PTPRO DAGLA SHISA6	5.22e-05	1018	177	22	GO:0098794
GeneOntologyCellularComponent	postsynaptic density membrane	CACNA1C LRFN1 CLSTN1 RYK TIAM1 PTPRO DAGLA SHISA6	5.90e-05	157	177	8	GO:0098839
GeneOntologyCellularComponent	nuclear protein-containing complex	DHX16 SIN3B POLR3K EXOSC10 HIF1A OGT WWOX GATAD2A POLE SIN3A CUL7 TEP1 RANBP17 INTS14 THRA THRB SUPT6H PABPC3 NUP133 HDAC10 NCR1 TAF10 TAF1L CPSF3 CREB3 XPO7	9.94e-05	1377	177	26	GO:0140513
GeneOntologyCellularComponent	postsynaptic membrane	GABRB2 CACNA1C LRFN1 RAPSN NBEA CLSTN1 RYK MET TIAM1 PTPRO DAGLA SHISA6	1.82e-04	405	177	12	GO:0045211
GeneOntologyCellularComponent	cell leading edge	SORBS2 GBF1 MYO9B ASAP3 APP TIAM1 PTPRO PABPC3 ROBO1 RIPOR1 DAGLA SHISA6 PLCE1	3.49e-04	500	177	13	GO:0031252
GeneOntologyCellularComponent	histone deacetylase complex	SIN3B OGT GATAD2A SIN3A HDAC10	7.81e-04	85	177	5	GO:0000118
GeneOntologyCellularComponent	Sin3-type complex	SIN3B OGT SIN3A	8.16e-04	22	177	3	GO:0070822
GeneOntologyCellularComponent	dendritic spine	ANKS1B APP CLSTN1 TIAM1 SYT11 PTPRO DAGLA SHISA6	1.09e-03	242	177	8	GO:0043197
GeneOntologyCellularComponent	neuron spine	ANKS1B APP CLSTN1 TIAM1 SYT11 PTPRO DAGLA SHISA6	1.25e-03	247	177	8	GO:0044309
GeneOntologyCellularComponent	presynaptic active zone	GABRB2 LRFN1 PCLO APP RYK SYT11	1.29e-03	141	177	6	GO:0048786
GeneOntologyCellularComponent	synaptic membrane	GABRB2 CACNA1C LRFN1 RAPSN NBEA CLSTN1 RYK MET TIAM1 SYT11 PTPRO DAGLA SHISA6	1.44e-03	583	177	13	GO:0097060
Domain	ARM-type_fold	PPP4R1 GBF1 USP24 FHOD3 NBEA CUL7 IPO4 SPAG6 WDFY4 RANBP17 THADA NBEAL2 RIPOR1 UNC79 TARBP1 XPO7	1.31e-07	339	175	16	IPR016024
Domain	ARM-like	PPP4R1 FHOD3 NBEA CUL7 IPO4 SPAG6 WDFY4 RANBP17 NBEAL2 RIPOR1 TARBP1 XPO7	9.48e-06	270	175	12	IPR011989
Domain	PH-BEACH_dom	NBEA WDFY4 NBEAL2	4.37e-05	8	175	3	IPR023362
Domain	-	NBEA WDFY4 NBEAL2	4.37e-05	8	175	3	2.30.29.40
Domain	PH_BEACH	NBEA WDFY4 NBEAL2	4.37e-05	8	175	3	PS51783
Domain	BEACH	NBEA WDFY4 NBEAL2	6.52e-05	9	175	3	PS50197
Domain	Beach	NBEA WDFY4 NBEAL2	6.52e-05	9	175	3	PF02138
Domain	-	NBEA WDFY4 NBEAL2	6.52e-05	9	175	3	1.10.1540.10
Domain	Beach	NBEA WDFY4 NBEAL2	6.52e-05	9	175	3	SM01026
Domain	BEACH_dom	NBEA WDFY4 NBEAL2	6.52e-05	9	175	3	IPR000409
Domain	HDAC_interact	SIN3B SIN3A	8.73e-05	2	175	2	SM00761
Domain	Sin3_C	SIN3B SIN3A	8.73e-05	2	175	2	IPR031693
Domain	Sin3_corepress	SIN3B SIN3A	8.73e-05	2	175	2	PF08295
Domain	Sin3a_C	SIN3B SIN3A	8.73e-05	2	175	2	PF16879
Domain	HDAC_interact_dom	SIN3B SIN3A	8.73e-05	2	175	2	IPR013194
Domain	PH_dom-like	SH2B3 MCF2L2 ASAP3 ANKS1B NBEA ARHGEF17 WDFY4 SYNGAP1 TIAM1 ARHGEF10 NBEAL2 OSBPL5 PLCE1	1.96e-04	426	175	13	IPR011993
Domain	DUF4211	PRR12 QSER1	2.60e-04	3	175	2	PF13926
Domain	PAH	SIN3B SIN3A	2.60e-04	3	175	2	IPR003822
Domain	-	SIN3B SIN3A	2.60e-04	3	175	2	1.20.1160.11
Domain	PAH	SIN3B SIN3A	2.60e-04	3	175	2	PS51477
Domain	DUF4211	PRR12 QSER1	2.60e-04	3	175	2	IPR025451
Domain	PAH	SIN3B SIN3A	2.60e-04	3	175	2	PF02671
Domain	DH_1	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	3.09e-04	63	175	5	PS00741
Domain	-	NBEA TEP1 ARHGEF17 WDFY4 HIRA MET ZNF106 ARHGEF10 NBEAL2 NUP133 EIF3B	3.14e-04	333	175	11	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	NBEA TEP1 ARHGEF17 WDFY4 HIRA MET ZNF106 ARHGEF10 NBEAL2 NUP133 EIF3B	3.30e-04	335	175	11	IPR015943
Domain	IBN_N	IPO4 RANBP17 XPO7	3.39e-04	15	175	3	PF03810
Domain	IBN_N	IPO4 RANBP17 XPO7	4.14e-04	16	175	3	SM00913
Domain	RhoGEF	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	4.41e-04	68	175	5	SM00325
Domain	Importin-beta_N	IPO4 RANBP17 XPO7	4.99e-04	17	175	3	IPR001494
Domain	RhoGEF	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	5.05e-04	70	175	5	PF00621
Domain	DH_2	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	5.05e-04	70	175	5	PS50010
Domain	-	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	5.39e-04	71	175	5	1.20.900.10
Domain	DH-domain	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	5.39e-04	71	175	5	IPR000219
Domain	ThyrH_rcpt	THRA THRB	8.57e-04	5	175	2	IPR001728
Domain	DUF4704	NBEA NBEAL2	8.57e-04	5	175	2	IPR031570
Domain	DUF4704	NBEA NBEAL2	8.57e-04	5	175	2	PF15787
Domain	PH_BEACH	NBEA NBEAL2	1.28e-03	6	175	2	PF14844
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DHX16 SORBS2 ARHGEF17 ERBIN ZEB2 SYT11 JMJD6 SPHKAP RIPOR1 KATNIP ANKRD12 RAB11FIP4 SLC23A2 PLCE1 XPO7	3.72e-09	407	179	15	12693553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNA1C KLF8 HIF1A OGT WWOX APP TEP1 TTF1 NXN ERBIN DNAH1 RANBP17 THADA THRA THRB SUPT6H OSBPL5 CDK5RAP1 RIPOR1 KATNIP ANKRD12 GREB1 QSER1 DAGLA XPO7	2.07e-07	1489	179	25	28611215
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GABRB2 SORBS2 PCLO ATG2B USP24 ANKS1B PLPPR3 NBEA APP ERBIN GGT7 SYNGAP1 MET SYT11 ABCE1 SPHKAP TENM1 EIF3B CACYBP HSPA9 SHISA6	4.80e-07	1139	179	21	36417873
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SIN3B LRFN1 SORBS2 OGT ANKS1B NBEA SIRPA IPO4 ERBIN FAM81A ZEB2 HIRA SYNGAP1 PABPC3 SPHKAP SVIL QSER1 UNC79 HSPA9	6.43e-07	963	179	19	28671696
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	DHX16 PCLO ZEB2 JMJD6 NBEAL2 KATNIP GREB1	1.27e-06	105	179	7	9628581
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	OGT GATAD2A DSG2 SIN3A CUL7 APP TEP1 HMG20A OSM THADA INTS14 THRA C1orf226 ACAD11 KMT5B JMJD6 MTO1 TAF10 UNC80 KNL1	1.42e-06	1116	179	20	31753913
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX16 A2M PPP4R1 COL6A2 OGT POLE SIN3A CLSTN1 PRR12 ACAD11 ABCE1 GORASP1 CDK5RAP1 QSER1 PLCE1	1.56e-06	650	179	15	38777146
Pubmed	Interaction between the scaffold proteins CBP by IQGAP1 provides an interface between gene expression and cytoskeletal activity.	OGT ANKS1B APP HMG20A ZNF106 TIAM1	1.57e-06	69	179	6	32238831
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	DHX16 SIN3B GBF1 OGT GATAD2A MYO9B POLE SIN3A CUL7 TTF1 ZEB2 HIRA NUP133 QSER1 UQCRFS1 TAF10 XPO7	2.40e-06	857	179	17	25609649
Pubmed	Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.	SIN3A THRA THRB	2.65e-06	6	179	3	10207062
Pubmed	Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.	WWOX POLE USP24 APP HIRA THADA ACAD11 PRKCSH CPSF3 GPN3 HSPA9 KNL1 XPO7	4.39e-06	533	179	13	25544563
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX16 EXOSC10 POLE USP24 CUL7 IPO4 TTF1 ABCE1 SUPT6H ATAD2B NUP133 CPSF3 HSPA9 XPO7	8.12e-06	653	179	14	22586326
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SIN3B STBD1 ROR1 ERBIN SVIL CCSER2 NUP133 TENM1 DNMBP	9.77e-06	263	179	9	34702444
Pubmed	Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells.	COL6A2 SIRPA PHYH SUPT6H HSPA9	1.05e-05	56	179	5	19299420
Pubmed	Genetic Steroid-Resistant Nephrotic Syndrome Overview	PTPRO NUP133 PLCE1	1.10e-05	9	179	3	34436835
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PPP4R1 SORBS2 OGT MCF2L2 ANKS1B NBEA EYA3 APP ZEB2 HMG20A SYNGAP1 CYRIA RNF123 TIAM1 ARHGEF10 ROBO1 RAB11FIP4 CARS2 TARBP1 HSPA9	1.15e-05	1285	179	20	35914814
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SIN3B GATAD2A USP24 CUL7 IPO4 ZEB2 INTS14 QSER1 KNL1	1.70e-05	282	179	9	23667531
Pubmed	The functional interactome landscape of the human histone deacetylase family.	SIN3B GATAD2A ATG2B SIN3A HMG20A SVIL NUP133 ANKRD12 HDAC10	2.06e-05	289	179	9	23752268
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	DHX16 EXOSC10 OGT GATAD2A CENPC POLE SIN3A HMG20A JMJD6 ABCE1 SUPT6H NUP133 EIF3B QSER1 CACYBP CPSF3 XPO7	2.14e-05	1014	179	17	32416067
Pubmed	Homology and the evolution of vocal folds in the novel avian voice box.	VEGFC THRA VCAN	2.15e-05	11	179	3	38183987
Pubmed	Strain background effects and genetic modifiers of hearing in mice.	GIPC3 THRA THRB	2.15e-05	11	179	3	16579977
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	COL6A2 SIN3B OGT POLE SIN3A HIRA PRR12 ZNF106 INTS14 TAF10 KNL1	2.53e-05	453	179	11	29656893
Pubmed	Neurodevelopmental control by thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	11861164
Pubmed	Fundamentally distinct roles of thyroid hormone receptor isoforms in a thyrotroph cell line are due to differential DNA binding.	THRA THRB	2.63e-05	2	179	2	22570333
Pubmed	Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system.	THRA THRB	2.63e-05	2	179	2	10430610
Pubmed	Audiogenic seizure susceptibility in thyroid hormone receptor beta-deficient mice.	THRA THRB	2.63e-05	2	179	2	11496110
Pubmed	Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence.	ACE MET	2.63e-05	2	179	2	23006961
Pubmed	Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.	THRA THRB	2.63e-05	2	179	2	21622534
Pubmed	Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation.	THRA THRB	2.63e-05	2	179	2	10346821
Pubmed	Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation.	HIF1A WWOX	2.63e-05	2	179	2	25012504
Pubmed	Impaired hair growth and wound healing in mice lacking thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	25254665
Pubmed	Naturally Occurring Amino Acids in Helix 10 of the Thyroid Hormone Receptor Mediate Isoform-Specific TH Gene Regulation.	THRA THRB	2.63e-05	2	179	2	28911178
Pubmed	Hormone selectivity in thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	11222741
Pubmed	APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer's Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression.	HIF1A APP	2.63e-05	2	179	2	36362046
Pubmed	Human bleomycin hydrolase regulates the secretion of amyloid precursor protein.	APP BLMH	2.63e-05	2	179	2	10973933
Pubmed	Effects of thyroid hormone receptor gene disruption on myosin isoform expression in mouse skeletal muscles.	THRA THRB	2.63e-05	2	179	2	10848522
Pubmed	Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	15780976
Pubmed	TRα protects against atherosclerosis in male mice: identification of a novel anti-inflammatory property for TRα in mice.	THRA THRB	2.63e-05	2	179	2	24797634
Pubmed	Suppression of the deafness and thyroid dysfunction in Thrb-null mice by an independent mutation in the Thra thyroid hormone receptor alpha gene.	THRA THRB	2.63e-05	2	179	2	11726557
Pubmed	Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.	APP ACE	2.63e-05	2	179	2	26748546
Pubmed	Establishment of yeast reporter assay systems to detect ligands of thyroid hormone receptors alpha and beta.	THRA THRB	2.63e-05	2	179	2	19853653
Pubmed	Locomotor deficiencies and aberrant development of subtype-specific GABAergic interneurons caused by an unliganded thyroid hormone receptor alpha1.	THRA THRB	2.63e-05	2	179	2	18287507
Pubmed	The two major isoforms of thyroid hormone receptor, TRα1 and TRβ1, preferentially partner with distinct panels of auxiliary proteins.	THRA THRB	2.63e-05	2	179	2	24325866
Pubmed	Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1.	THRA THRB	2.63e-05	2	179	2	12356724
Pubmed	The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production.	THRA THRB	2.63e-05	2	179	2	9250685
Pubmed	Isometric force and endurance in skeletal muscle of mice devoid of all known thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	12562961
Pubmed	The c-erb-A gene encodes a thyroid hormone receptor.	THRA THRB	2.63e-05	2	179	2	2879243
Pubmed	Distinct behavioral phenotypes in male mice lacking the thyroid hormone receptor α1 or β isoforms.	THRA THRB	2.63e-05	2	179	2	23567476
Pubmed	Novel non-genomic signaling of thyroid hormone receptors in thyroid carcinogenesis.	THRA THRB	2.63e-05	2	179	2	19549593
Pubmed	Gestational di-(2-ethylhexyl) phthalate exposure causes fetal intrauterine growth restriction through disturbing placental thyroid hormone receptor signaling.	THRA THRB	2.63e-05	2	179	2	29753845
Pubmed	Thyroxine-thyroid hormone receptor interactions.	THRA THRB	2.63e-05	2	179	2	15466465
Pubmed	Isometric force and endurance in soleus muscle of thyroid hormone receptor-alpha(1)- or -beta-deficient mice.	THRA THRB	2.63e-05	2	179	2	10712278
Pubmed	Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.	HIF1A DSG2	2.63e-05	2	179	2	33431674
Pubmed	Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1.	THRA THRB	2.63e-05	2	179	2	15858214
Pubmed	Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma.	THRA THRB	2.63e-05	2	179	2	20062085
Pubmed	Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1.	THRA THRB	2.63e-05	2	179	2	17932484
Pubmed	The intracellular localization of amyloid beta protein precursor (AbetaPP) intracellular domain associated protein-1 (AIDA-1) is regulated by AbetaPP and alternative splicing.	ANKS1B APP	2.63e-05	2	179	2	15004329
Pubmed	Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	11867729
Pubmed	Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor-beta or both alpha1 and beta.	THRA THRB	2.63e-05	2	179	2	10362681
Pubmed	Brain glucose utilization in mice with a targeted mutation in the thyroid hormone alpha or beta receptor gene.	THRA THRB	2.63e-05	2	179	2	11481455
Pubmed	Clinical relevance of thyroid dysfunction in human haematopoiesis: biochemical and molecular studies.	THRA THRB	2.63e-05	2	179	2	19903799
Pubmed	Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production.	APP CLSTN1	2.63e-05	2	179	2	22434822
Pubmed	Functionally impaired TR mutants are present in thyroid papillary cancer.	THRA THRB	2.63e-05	2	179	2	11889175
Pubmed	Immunohistochemical expression and prognostic significance of HIF-1α and VEGF-C in neuroendocrine breast cancer.	VEGFC HIF1A	2.63e-05	2	179	2	23225420
Pubmed	Calsyntenin-1 shelters APP from proteolytic processing during anterograde axonal transport.	APP CLSTN1	2.63e-05	2	179	2	23213470
Pubmed	Targeted gene sequencing and whole-exome sequencing in autopsied fetuses with prenatally diagnosed kidney anomalies.	ROBO1 GREB1	2.63e-05	2	179	2	29194579
Pubmed	Gene expression profiling provides insights into pathways of oxaliplatin-related sinusoidal obstruction syndrome in humans.	VEGFC HIF1A	2.63e-05	2	179	2	21330458
Pubmed	Deafness in TRbeta mutants is caused by malformation of the tectorial membrane.	THRA THRB	2.63e-05	2	179	2	19244534
Pubmed	Thyroid Hormone Facilitates in vitro Decidualization of Human Endometrial Stromal Cells via Thyroid Hormone Receptors.	THRA THRB	2.63e-05	2	179	2	32242219
Pubmed	Ligand Independent and Subtype-Selective Actions of Thyroid Hormone Receptors in Human Adipose Derived Stem Cells.	THRA THRB	2.63e-05	2	179	2	27732649
Pubmed	The oligomeric state of thyroid receptor regulates hormone binding kinetics.	THRA THRB	2.63e-05	2	179	2	21508093
Pubmed	Isolation and characterization of mouse complementary DNAs encoding alpha and beta thyroid hormone receptors from thyrotrope cells: the mouse pituitary-specific beta 2 isoform differs at the amino terminus from the corresponding species from rat pituitary tumor cells.	THRA THRB	2.63e-05	2	179	2	1944303
Pubmed	ABCE1 selectively promotes HIF-1α transactivation of angiogenic gene expression.	HIF1A ABCE1	2.63e-05	2	179	2	37738929
Pubmed	Thyroid hormone excess rather than thyrotropin deficiency induces osteoporosis in hyperthyroidism.	THRA THRB	2.63e-05	2	179	2	17327419
Pubmed	The thyroid hormone receptors modulate the skin response to retinoids.	THRA THRB	2.63e-05	2	179	2	21858227
Pubmed	Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.	VEGFC HIF1A	2.63e-05	2	179	2	18630523
Pubmed	TRs have common and isoform-specific functions in regulation of the cardiac myosin heavy chain genes.	THRA THRB	2.63e-05	2	179	2	11731612
Pubmed	Thyroid status during skeletal development determines adult bone structure and mineralization.	THRA THRB	2.63e-05	2	179	2	17488972
Pubmed	Protein Tyrosine Phosphatase PTPRO Signaling Couples Metabolic States to Control the Development of Granulocyte Progenitor Cells.	HIF1A PTPRO	2.63e-05	2	179	2	35246496
Pubmed	Life Without Thyroid Hormone Receptor.	THRA THRB	2.63e-05	2	179	2	33558878
Pubmed	Isoform-specific transcriptional activity of overlapping target genes that respond to thyroid hormone receptors alpha1 and beta1.	THRA THRB	2.63e-05	2	179	2	19628582
Pubmed	Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor alpha or beta.	THRA THRB	2.63e-05	2	179	2	11159823
Pubmed	Cytoplasmic fragment of Alcadein α generated by regulated intramembrane proteolysis enhances amyloid β-protein precursor (APP) transport into the late secretory pathway and facilitates APP cleavage.	APP CLSTN1	2.63e-05	2	179	2	25406318
Pubmed	Differential Complex Formation via Paralogs in the Human Sin3 Protein Interaction Network.	SIN3B SIN3A	2.63e-05	2	179	2	32467258
Pubmed	Adaptor protein Lnk inhibits c-Fms-mediated macrophage function.	SH2B3 CSF1R	2.63e-05	2	179	2	20571037
Pubmed	Thyroid hormone receptor-α and vascular function.	THRA THRB	2.63e-05	2	179	2	22322976
Pubmed	Epistatic interaction of genetic depression risk variants in the human subgenual cingulate cortex during memory encoding.	CACNA1C PCLO	2.63e-05	2	179	2	24643163
Pubmed	A Direct Comparison of Thyroid Hormone Receptor Protein Levels in Mice Provides Unexpected Insights into Thyroid Hormone Action.	THRA THRB	2.63e-05	2	179	2	32122258
Pubmed	Depressed thermogenesis but competent brown adipose tissue recruitment in mice devoid of all hormone-binding thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	14630998
Pubmed	A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain.	PAG1 HIF1A	2.63e-05	2	179	2	23671581
Pubmed	Thyroid hormone-stimulated differentiation of primary rib chondrocytes in vitro requires thyroid hormone receptor beta.	THRA THRB	2.63e-05	2	179	2	17065405
Pubmed	Thyroid hormone receptor-α deletion decreases heart function and exercise performance in apolipoprotein E-deficient mice.	THRA THRB	2.63e-05	2	179	2	26672044
Pubmed	Thyroid hormone receptor beta-dependent expression of a potassium conductance in inner hair cells at the onset of hearing.	THRA THRB	2.63e-05	2	179	2	9861043
Pubmed	Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression.	OGT SIN3A	2.63e-05	2	179	2	12150998
Pubmed	Comparative Phenotyping of Mice Reveals Canonical and Noncanonical Physiological Functions of TRα and TRβ.	THRA THRB	2.63e-05	2	179	2	38889231
Pubmed	Retardation of cochlear maturation and impaired hair cell function caused by deletion of all known thyroid hormone receptors.	THRA THRB	2.63e-05	2	179	2	11739587
Pubmed	Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism.	THRA THRB	2.63e-05	2	179	2	19282388
Pubmed	Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis.	THRA THRB	2.63e-05	2	179	2	20141582
Pubmed	Compensatory role of thyroid hormone receptor (TR) alpha 1 in resistance to thyroid hormone: study in mice with a targeted mutation in the TR beta gene and deficient in TR alpha 1.	THRA THRB	2.63e-05	2	179	2	12750454
Pubmed	Canonical and Noncanonical Contribution of Thyroid Hormone Receptor Isoforms Alpha and Beta to Cardiac Hypertrophy and Heart Rate in Male Mice.	THRA THRB	2.63e-05	2	179	2	38757582
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA WDFY4 NBEAL2	2.89e-05	9	129	3	1230
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	MCF2L2 ARHGEF17 TIAM1 ARHGEF10 DNMBP	1.08e-04	66	129	5	722
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	ROR1 RYK MET CSF1R	1.85e-04	40	129	4	321
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	VEGFC HIF1A GBF1 OGT CENPC MYO9B ROR1 USP24 EXT1 APP ZEB2 RYK HIRA TIAM1 ARHGEF10 ABCE1 ATAD2B CCSER2 NUP133 DNMBP SLC23A2 PLCE1	9.41e-08	856	178	22	M4500
Coexpression	GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN	DHX16 POLR3K GBF1 NXN RYK HIRA SEPHS1 SYT11 NUP133 KNL1	3.91e-07	177	178	10	M6703
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	KANSL1L SORBS2 WWOX FHOD3 NBEA EXT1 RHEX SVIL PKHD1	3.44e-06	176	178	9	M39223
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN	VEGFC COL6A2 SIN3B POLR3K STBD1 PCLO USP24 APP TEP1 ZEB2 MET ZNF106 CYRIA THRA RRAGD SUPT6H VCAN PLCE1	3.61e-06	746	178	18	M40863
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	GBF1 CENPC MYO9B POLE ATG2B USP24 ZNF106 THRB ATAD2B	4.14e-06	180	178	9	M8239
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GABRB2 CACNA1C PCLO ANKS1B FHOD3 NBEA SIN3A FAM81A IKZF4 CYRIA FAT2 THRA KIAA1549L PTPRO VCAN SCN9A TENM1 ROBO1 ANKRD12 RAB11FIP4 UNC79 TARBP1	6.53e-06	1106	178	22	M39071
Coexpression	GSE29618_PDC_VS_MDC_UP	UBA5 OGT USP24 APP PTGDS SEPHS1 SCN9A RIPOR1 TARBP1	8.96e-06	198	178	9	M4951
Coexpression	GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN	VEGFC GABRB2 CACNA1C NLRX1 RANBP17 PDILT CCSER2 SCN9A SLC23A2	9.33e-06	199	178	9	M8065
Coexpression	ZHONG_PFC_C3_ASTROCYTE	SIN3B PCLO NBEA ZEB2 CEP164 SYCP2 THRB SPHKAP ATAD2B SCN9A PRKCSH UNC79	1.53e-05	389	178	12	M39102
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	CENPC MYO9B ZEB2 ARHGEF10 ABCE1 PLCE1	2.53e-05	85	178	6	M10575
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	GABRB2 CACNA1C PCLO FHOD3 NBEA SIRPA WDFY4 IKZF4 KIAA1549L SCN9A TENM1 ROBO1 ANKRD12 RAB11FIP4 UNC79 TARBP1	2.62e-05	703	178	16	M39070
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	MUC16 EYA3 APP ARHGEF17 CYRIA CLCN5 SYT11 PTPRO GRHL3	4.81e-05	245	178	9	M18095
Coexpression	GSE22886_NAIVE_TCELL_VS_NKCELL_DN	STBD1 NLRX1 MCF2L2 HIRA CYRIA NUP133 NCR1 UEVLD	6.56e-05	198	178	8	M4415
Coexpression	GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN	ATG2B HMG20A SEPHS1 ABCE1 EIF3B CACYBP SLC23A2 XPO7	6.80e-05	199	178	8	M8974
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	DHX16 SH2B3 PTPRO NFE2L1 SCN9A UQCRFS1 TAF10 SLC23A2	6.80e-05	199	178	8	M5240
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	DHX16 OGT PARP8 TTF1 ZNF106 ATAD2B SVIL XPO7	7.04e-05	200	178	8	M8485
Coexpression	RODWELL_AGING_KIDNEY_NO_BLOOD_DN	DSG2 PCLO PHYH THRB C1orf226 MTO1 HSPA9	7.08e-05	148	178	7	M11837
Coexpression	MURARO_PANCREAS_BETA_CELL	CENPC PCLO ROR1 NBEA SLC2A2 ZNF106 PER3 RRAGD TIAM1 SYT11 NFE2L1 CCSER2 ROBO1 ANKRD12 CACYBP UNC79 HSPA9 UNC80	8.38e-05	946	178	18	M39169
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	MUC16 EYA3 APP ARHGEF17 CYRIA CLCN5 SYT11 PTPRO GRHL3	9.30e-05	267	178	9	MM984
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 A2M PCLO DNAH1 SYCP2 SCN9A PKHD1 TENM1 ROBO1 ATP1A4 UNC79 UNC80 PLCE1	6.43e-13	184	179	13	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 A2M PCLO DNAH1 SYCP2 SCN9A PKHD1 TENM1 ROBO1 ATP1A4 UNC79 UNC80 PLCE1	6.43e-13	184	179	13	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRB2 A2M PCLO DNAH1 SYCP2 SCN9A PKHD1 TENM1 ROBO1 ATP1A4 UNC79 UNC80 PLCE1	6.43e-13	184	179	13	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 CACNA1C SORBS2 PCLO ANKS1B NBEA THRB KIAA1549L UNC79 TARBP1 UNC80	4.74e-10	196	179	11	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 CACNA1C SORBS2 PCLO ANKS1B NBEA THRB KIAA1549L UNC79 TARBP1 UNC80	5.28e-10	198	179	11	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 CACNA1C SORBS2 PCLO ANKS1B NBEA THRB KIAA1549L UNC79 TARBP1 UNC80	5.28e-10	198	179	11	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	GABRB2 CACNA1C SORBS2 PCLO ANKS1B NBEA THRB KIAA1549L UNC79 TARBP1 UNC80	5.87e-10	200	179	11	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 CACNA1C SORBS2 PCLO ANKS1B NBEA THRB KIAA1549L UNC79 UNC80	8.20e-09	198	179	10	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 CACNA1C SORBS2 PCLO NBEA THRB KIAA1549L UNC79 TARBP1 UNC80	8.20e-09	198	179	10	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	CACNA1C PCLO PLPPR3 NBEA ZEB2 THRA THRB SCN9A TENM1 ANKRD12	9.03e-09	200	179	10	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C POLE ANKS1B KIAA1549L PDILT SCN9A PKHD1 TENM1 UNC80	2.04e-08	162	179	9	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	A2M CACNA1C PAG1 ANKS1B SYT11 MAMDC2 ROBO1 GREB1 UNC80	8.83e-08	192	179	9	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	PAG1 SH2B3 MYO9B SIRPA WDFY4 ZEB2 CYRIA TIAM1 VCAN	1.15e-07	198	179	9	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	VEGFC KANSL1L EXOSC10 SORBS2 APP CLSTN1 RHEX VCAN PKHD1	1.20e-07	199	179	9	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	Bronchial-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PAG1 SH2B3 MYO9B SIRPA WDFY4 ZEB2 CYRIA CSF1R TIAM1	1.25e-07	200	179	9	2f5b71e55c2de0e77fdae6667eb57f333acc6cd1
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	KANSL1L USP24 ASAP3 WDFY4 ERBIN CSF1R PER3 NFE2L1	3.14e-07	162	179	8	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	facs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WWOX PARP8 M1AP MET ZNF106 OSM ACAD11 UEVLD	3.79e-07	166	179	8	5c132f505dc5f699c87913f140344fc9f8e7e0f5
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIRPA APP TEP1 ZEB2 MET CSF1R PTPRO VCAN	5.66e-07	175	179	8	69b59ec58e64644deb7e07f31ef495ef4a6f6276
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	APP PTGDS IGSF10 RHEX CSF1R CLCN5 SCN9A C22orf15	5.66e-07	175	179	8	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIRPA APP TEP1 ZEB2 MET CSF1R PTPRO VCAN	5.66e-07	175	179	8	4f7498b5a0ed52c348a5f94bcd41d830ba7954ea
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYO9B WDFY4 ERBIN ZEB2 CYRIA ARHGEF10 SYT11 DNMBP	7.93e-07	183	179	8	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC COL6A2 ZC3H12B ARHGEF17 GGT7 IGSF10 RRAGD MAMDC2	8.61e-07	185	179	8	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC COL6A2 ZC3H12B ARHGEF17 GGT7 IGSF10 RRAGD MAMDC2	8.61e-07	185	179	8	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEGFC COL6A2 ZC3H12B ARHGEF17 GGT7 IGSF10 RRAGD MAMDC2	8.61e-07	185	179	8	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	Control\|World / Disease state, Lineage and Cell class	HIF1A SH2B3 MYO9B SIRPA ZEB2 OSM SUPT6H VCAN	1.01e-06	189	179	8	fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SH2B3 PARP8 WDFY4 ZEB2 CYRIA CSF1R VCAN	1.38e-06	197	179	8	c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A2 ROR1 PTGDS ZEB2 IGSF10 THRB TIAM1 VCAN	1.38e-06	197	179	8	31a1852911bda38543916585fda34255fd62a134
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PAG1 MYO9B MCF2L2 SIRPA WDFY4 ZEB2 TIAM1 PTPRO	1.43e-06	198	179	8	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231\|Adult / Lineage, Cell type, age group and donor	HIF1A MYO9B MCF2L2 SIRPA ZEB2 CYRIA OSM VCAN	1.43e-06	198	179	8	79a415e19cedde13a88f5043d71557363f102322
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PAG1 MYO9B MCF2L2 SIRPA WDFY4 ZEB2 TIAM1 PTPRO	1.43e-06	198	179	8	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GABRB2 CACNA1C PCLO ANKS1B NBEA KIAA1549L UNC79 UNC80	1.43e-06	198	179	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SH2B3 MYO9B WDFY4 ZEB2 CYRIA CSF1R TIAM1	1.43e-06	198	179	8	623f9d64c9e800d2d7f623392bf2f22b563f0249
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PAG1 SH2B3 MYO9B SIRPA WDFY4 ZEB2 CSF1R TIAM1	1.49e-06	199	179	8	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SH2B3 MYO9B SIRPA WDFY4 ZEB2 CYRIA CSF1R VCAN	1.54e-06	200	179	8	5432bdf495431cd26f6e4cd585100f3652588913
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SORBS2 PARP8 PTPRO TMEM132D VCAN SCN9A TENM1 UNC80	1.54e-06	200	179	8	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SORBS2 PARP8 PTPRO TMEM132D VCAN SCN9A TENM1 UNC80	1.54e-06	200	179	8	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SORBS2 PARP8 PTPRO TMEM132D VCAN SCN9A TENM1 UNC80	1.54e-06	200	179	8	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A2 ANKS1B ZEB2 MET MAMDC2 SPHKAP VCAN ROBO1	1.54e-06	200	179	8	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SORBS2 PARP8 PTPRO TMEM132D VCAN SCN9A TENM1 UNC80	1.54e-06	200	179	8	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SORBS2 PARP8 PTPRO TMEM132D VCAN SCN9A TENM1 UNC80	1.54e-06	200	179	8	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SORBS2 PARP8 PTPRO TMEM132D VCAN SCN9A TENM1 UNC80	1.54e-06	200	179	8	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SH2B3 MYO9B SIRPA WDFY4 ZEB2 CYRIA CSF1R VCAN	1.54e-06	200	179	8	b4277b6faa69f20974696c7c422311f5c89e3663
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ROR1 MCF2L2 NBEA ARHGEF17 ZEB2 ROBO1	3.76e-06	159	179	7	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	IPF-Epithelial-Ionocyte\|World / Disease state, Lineage and Cell class	GABRB2 DSG2 PCLO ROR1 MUC16 FHOD3 SCN9A	4.08e-06	161	179	7	f1cd5c938cdc08ad8995371b72493850a6cf277a
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	KANSL1L SIN3B USP24 SYNGAP1 RNF123 NUP133 KATNIP	5.00e-06	166	179	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	mild_COVID-19-HSPC\|mild_COVID-19 / disease group, cell group and cell class (v2)	CACNA1C DSG2 ZC3H12B SPAG6 RANBP17 MAMDC2 DYNLT5	5.40e-06	168	179	7	90b33962adb77d8326dee403712118398b4d1315
ToppCell	mild_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	CACNA1C DSG2 ZC3H12B SPAG6 RANBP17 MAMDC2 DYNLT5	5.84e-06	170	179	7	85c476e0bc496445e868a88849960598d97bdea2
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ROR1 MCF2L2 NBEA ARHGEF17 ZEB2 ROBO1	5.84e-06	170	179	7	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ROR1 MCF2L2 NBEA ARHGEF17 ZEB2 ROBO1	5.84e-06	170	179	7	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SH2B3 MUC16 WDFY4 ZEB2 CYRIA OSM CSF1R	6.31e-06	172	179	7	72fbfa890995e47048b47199c170cc7dcd7661f8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SH2B3 MUC16 WDFY4 ZEB2 CYRIA OSM CSF1R	6.31e-06	172	179	7	2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	MUC16 NBEA MET SYCP2 SCGB1A1 UGT2A1 SHISA6	6.80e-06	174	179	7	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPP4R1 USP24 PTGDS ACE HMG20A CSF1R C1orf226	7.06e-06	175	179	7	c1c722db42da9b8a2a46e516ddb83d9be5e2e504
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	APP PTGDS IGSF10 CSF1R CLCN5 SCN9A C22orf15	7.33e-06	176	179	7	d6e660df92a3d7dd5732171ee623763faf108476
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-monocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEP1 ACE ZEB2 CYRIA CSF1R PTPRO VCAN	7.33e-06	176	179	7	1bf8fed48bd224f09efe90a38233b1f01d7311fe
ToppCell	facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 FAM81A SYCP2 MAMDC2 PDILT DNMBP PLCE1	7.61e-06	177	179	7	32fecefba1a55e1f418c9a055236fa11175c692d
ToppCell	facs-Heart-LA-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORBS2 FAM81A SYCP2 MAMDC2 PDILT DNMBP PLCE1	7.61e-06	177	179	7	1b153fbfe1323dc589de4af73a52149ea5ce6763
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	MUC16 NBEA MET SYCP2 SCGB1A1 UGT2A1 SHISA6	8.19e-06	179	179	7	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	COL6A2 PAG1 FHOD3 RHEX THRB VCAN PLCE1	8.19e-06	179	179	7	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CACNA1C COL6A2 OMD PTGDS IGSF10 MAMDC2 SPHKAP	8.19e-06	179	179	7	10fadbaa1b6d21cbf9f354d717cc4c225619f4fd
ToppCell	COVID-19-kidney-PCT-S2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PCLO FHOD3 SLC2A2 MET RHEX PKHD1 TENM1	8.49e-06	180	179	7	358923e4228035a3e90e2957392089219e90dcd7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ROR1 SVIL SCN9A TENM1 DYNLT5 ROBO1 PLCE1	8.80e-06	181	179	7	af92b8b7f455210dab502ef6964f3a0162180759
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ROR1 SVIL SCN9A TENM1 DYNLT5 ROBO1 PLCE1	9.12e-06	182	179	7	d4cb23b5a974c096a0ce84b47fe351eef44894d7
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	SORBS2 MUC16 NBEA MET SYCP2 SCGB1A1 UGT2A1	9.45e-06	183	179	7	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ROR1 SVIL SCN9A TENM1 DYNLT5 ROBO1 PLCE1	9.80e-06	184	179	7	7d41784eac0935e77d6bc701f20c693adf998730
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 NXN RHEX THRB TMEM132D ROBO1 PLCE1	1.01e-05	185	179	7	8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 NXN RHEX THRB TMEM132D ROBO1 PLCE1	1.01e-05	185	179	7	34fcfd635c828dad9643bbf1c908d79282d6f5d9
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PCLO MUC16 SIRPA ZEB2 VCAN PKHD1 HDAC10	1.05e-05	186	179	7	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COPD-Myeloid-cMonocyte\|COPD / Disease state, Lineage and Cell class	HIF1A EXT1 ZEB2 CYRIA OSM VCAN DNMBP	1.17e-05	189	179	7	d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SH2B3 WDFY4 ZEB2 CYRIA OSM CSF1R	1.17e-05	189	179	7	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	A2M CACNA1C COL6A2 PTGDS MAMDC2 VCAN ROBO1	1.21e-05	190	179	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Control-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	SORBS2 EXT1 OMD PTGDS MET THRB ROBO1	1.21e-05	190	179	7	4e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCell	droplet-Marrow-nan-21m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STBD1 APP TEP1 ZEB2 MET CSF1R PTPRO	1.21e-05	190	179	7	6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	GABRB2 A2M COL6A2 OMD IGSF10 MAMDC2 TENM1	1.25e-05	191	179	7	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	GABRB2 A2M COL6A2 OMD IGSF10 MAMDC2 TENM1	1.25e-05	191	179	7	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	15-Trachea-Epithelial-Intermediate_ciliated\|Trachea / Age, Tissue, Lineage and Cell class	ODAD1 MUC16 PLPPR3 NBEA SPAG6 DYNLT5 C22orf15	1.29e-05	192	179	7	9cbe961a800c981cdc742a47ed18e9c8eb6430bd
ToppCell	Control-Myeloid-cMonocyte\|Control / Disease state, Lineage and Cell class	HIF1A MYO9B EXT1 ZEB2 CYRIA VCAN DNMBP	1.29e-05	192	179	7	ad04c9c4bdebf94615cee1904ca48197e62c923b
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	A2M PAG1 OGT MCF2L2 USP24 ATAD2B ANKRD12	1.34e-05	193	179	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KANSL1L PCLO FHOD3 MET THRB CLCN5 PKHD1	1.38e-05	194	179	7	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	Control-Myeloid-Macrophage\|World / Disease state, Lineage and Cell class	HIF1A MYO9B SIRPA ZEB2 CYRIA OSM VCAN	1.38e-05	194	179	7	c35bf04d5e7450cb6679a036fcabb1b28f409f29
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ROR1 ANKS1B ZEB2 THRB TIAM1 VCAN ROBO1	1.38e-05	194	179	7	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	HIF1A SH2B3 MYO9B ZEB2 CYRIA OSM CSF1R	1.38e-05	194	179	7	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAG1 SH2B3 MYO9B ZEB2 CYRIA CSF1R VCAN	1.43e-05	195	179	7	10ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A2 WWOX ANKS1B NXN MAMDC2 VCAN ROBO1	1.43e-05	195	179	7	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Control-Myeloid\|Control / Disease state, Lineage and Cell class	HIF1A MYO9B MCF2L2 SIRPA ZEB2 CYRIA VCAN	1.43e-05	195	179	7	46ce2e403ca5d757e5ba17349b6c7ce5cde1f195
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	VEGFC A2M CACNA1C COL6A2 IGSF10 MAMDC2 ROBO1	1.43e-05	195	179	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A2 OMD ADGRG4 IGSF10 MAMDC2 VCAN GREB1	1.43e-05	195	179	7	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBF1 PCLO SIRPA ARHGEF17 SLC2A2 SPHKAP UNC80	1.43e-05	195	179	7	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A2 PAG1 PTGDS RHEX MAMDC2 VCAN PLCE1	1.48e-05	196	179	7	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A2 PAG1 PTGDS RHEX MAMDC2 VCAN PLCE1	1.48e-05	196	179	7	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area\|World / Primary Cells by Cluster	GABRB2 PCLO NBEA CYRIA SPHKAP VCAN ANKRD12	1.52e-05	197	179	7	79b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M CACNA1C COL6A2 MAMDC2 VCAN TENM1 ROBO1	1.52e-05	197	179	7	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	normal_Lung-Myeloid_cells-Monocytes\|normal_Lung / Location, Cell class and cell subclass	HIF1A SH2B3 ZEB2 CYRIA OSM CSF1R VCAN	1.52e-05	197	179	7	f32f1a0455c2cfdd5f187b10f6a3fd4877874c09
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SH2B3 MYO9B WDFY4 ZEB2 CYRIA CSF1R VCAN	1.52e-05	197	179	7	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	VEGFC A2M CACNA1C COL6A2 ROR1 VCAN ROBO1	1.52e-05	197	179	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33\|World / Primary Cells by Cluster	GABRB2 PCLO NBEA CYRIA SPHKAP VCAN ANKRD12	1.52e-05	197	179	7	d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL6A2 OMD PTGDS ZEB2 VCAN ATP1A4	1.52e-05	197	179	7	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1C PTGDS ZEB2 IGSF10 THRB SPHKAP VCAN	1.52e-05	197	179	7	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	A2M CACNA1C COL6A2 ROR1 PTGDS VCAN ROBO1	1.52e-05	197	179	7	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HIF1A SH2B3 SIRPA ZEB2 CYRIA CSF1R VCAN	1.58e-05	198	179	7	3a1707318814dabdec48f91fa6bd223f5b879653
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	HIRA MET SYCP2 THRA CSF1R CLCN5 CLCN6 RIPOR1 ANKRD12 DAGLA	3.29e-06	196	177	10	3199_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	RAPSN ROR1 ACE CREB3L1 CLCN5 CLCN6 ARHGEF10 SYT11 RIPOR1 QSER1	3.44e-06	197	177	10	6737_DN
Drug	2,4,5-trichlorophenol	OGT WWOX ACE SLC2A2 JMJD6 SLC23A2	4.77e-06	56	177	6	CID000007271
Disease	Autistic Disorder	CACNA1C NBEA EXT1 CUL7 ACE WDFY4 SYNGAP1 MET ROBO1	2.77e-05	261	175	9	C0004352
Disease	thyroid hormone resistance syndrome (implicated_via_orthology)	THRA THRB	1.05e-04	3	175	2	DOID:11633 (implicated_via_orthology)
Disease	gastrinoma (is_marker_for)	SLC2A2 MET	1.05e-04	3	175	2	DOID:5577 (is_marker_for)
Disease	Mental Depression	A2M CACNA1C HIF1A PCLO APP RNF123 PER3 ARHGEF10	1.46e-04	254	175	8	C0011570
Disease	facial attractiveness measurement	EXT1 NXN RAB11FIP4	1.85e-04	19	175	3	EFO_0009892
Disease	developmental disorder of mental health (implicated_via_orthology)	GABRB2 SIN3B SIN3A SYNGAP1	2.06e-04	49	175	4	DOID:0060037 (implicated_via_orthology)
Disease	mean arterial pressure	MYO9B NXN CREB3L1 RYK IKZF4 THADA CLCN6 PDILT PKHD1 ROBO1 PLCE1	2.07e-04	499	175	11	EFO_0006340
Disease	Generalized Thyroid Hormone Resistance	THRA THRB	2.08e-04	4	175	2	C4722330
Disease	neuroimaging measurement	RAPSN WWOX GATAD2A ROR1 EXT1 ZNF106 CYRIA OSM THADA ACAD11 PABPC3 VCAN PKHD1 ROBO1 PRKCSH QSER1 PLCE1	2.23e-04	1069	175	17	EFO_0004346
Disease	level of Phosphatidylcholine (18:1_20:4) in blood serum	RAPSN GATAD2A DAGLA	2.52e-04	21	175	3	OBA_2045104
Disease	level of Phosphatidylcholine (16:0_20:4) in blood serum	RAPSN SCGB1A1 DAGLA	2.52e-04	21	175	3	OBA_2045076
Disease	retinal vasculature measurement	DHX16 CACNA1C SORBS2 SH2B3 TXNRD2 HMG20A ZNF106 TMEM132D SHISA6 KNL1 PLCE1	2.80e-04	517	175	11	EFO_0010554
Disease	autism spectrum disorder (implicated_via_orthology)	NBEA EXT1 SYNGAP1 MET ARHGEF10 KMT5B	3.03e-04	152	175	6	DOID:0060041 (implicated_via_orthology)
Disease	Depressive disorder	A2M CACNA1C PCLO APP ACE RNF123 PER3 ARHGEF10	3.48e-04	289	175	8	C0011581
Disease	serum gamma-glutamyl transferase measurement	SORBS2 ASAP3 SLC2A2 MET THADA THRB SYT11 NBEAL2 RP1L1 SVIL SCGB1A1 PKHD1 ROBO1 DNMBP PLCE1	3.80e-04	914	175	15	EFO_0004532
Disease	cortical surface area measurement	DHX16 RAPSN WWOX MYO9B ROR1 EXT1 CLSTN1 ZNF106 CYRIA THADA ACAD11 VCAN ATAD2B RP1L1 PKHD1 ROBO1 RAB11FIP4 QSER1 PLCE1	4.21e-04	1345	175	19	EFO_0010736
Disease	lysophosphatidylethanolamine 18:2 measurement	RAPSN FAM81A DAGLA	4.82e-04	26	175	3	EFO_0010369
Disease	eye disease (implicated_via_orthology)	EYA3 RP1L1	5.16e-04	6	175	2	DOID:5614 (implicated_via_orthology)
Disease	Bipolar Disorder	GABRB2 CACNA1C HIF1A PCLO ROR1 APP PTGDS ACE PER3 ARHGEF10	5.92e-04	477	175	10	C0005586
Disease	platelet component distribution width	CACNA1C RAPSN SH2B3 MYO9B SIN3A SIRPA NXN CYRIA THRB NFE2L1 ATAD2B SVIL XPO7	6.02e-04	755	175	13	EFO_0007984
Disease	grapefruit juice consumption measurement	CACNA1C PCLO	7.20e-04	7	175	2	EFO_0010094
Disease	X-18899 measurement	UBA5 ACAD11	7.20e-04	7	175	2	EFO_0800793
Disease	osteonecrosis (biomarker_via_orthology)	A2M HIF1A	7.20e-04	7	175	2	DOID:10159 (biomarker_via_orthology)
Disease	right ventricular ejection fraction measurement	FHOD3 SVIL SLC23A2	7.40e-04	30	175	3	EFO_0021816
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	PTPRO NUP133 PLCE1	7.40e-04	30	175	3	C1868672
Disease	renal cell carcinoma (is_implicated_in)	MET THRA THRB CSF1R	7.65e-04	69	175	4	DOID:4450 (is_implicated_in)
Disease	level of Sterol ester (27:1/20:4) in blood serum	RAPSN SCGB1A1 DAGLA	8.16e-04	31	175	3	OBA_2045198
Disease	level of Phosphatidylcholine (18:0_20:4) in blood serum	RAPSN SCGB1A1 DAGLA	8.16e-04	31	175	3	OBA_2045094
Disease	lung cancer (is_implicated_in)	POLE ACE CSF1R DAGLA	9.95e-04	74	175	4	DOID:1324 (is_implicated_in)
Disease	cortical thickness	A2M RAPSN WWOX GATAD2A ROR1 EXT1 ZNF106 PHYH CYRIA THADA VCAN PKHD1 ROBO1 RAB11FIP4 QSER1 PLCE1	1.01e-03	1113	175	16	EFO_0004840
Disease	Colorectal Carcinoma	POLE PARP8 MCF2L2 ASAP3 NXN ZEB2 TIAM1 ABCE1 PDILT PKHD1 TENM1 NCR1	1.04e-03	702	175	12	C0009402
Disease	triacylglycerol 58:10 measurement	VEGFC RAPSN SCN9A	1.07e-03	34	175	3	EFO_0010437
Disease	hemoglobin A1 measurement	RAPSN SH2B3 MYO9B NLRX1 SLC2A2 HMG20A THADA INTS14 RP1L1 PRKCSH	1.14e-03	520	175	10	EFO_0007629
Disease	Lung diseases	A2M HIF1A ACE SCGB1A1	1.21e-03	78	175	4	C0024115
Disease	Mental deterioration	CACNA1C APP	1.23e-03	9	175	2	C0234985
Disease	lung cancer (implicated_via_orthology)	POLE ROBO1	1.23e-03	9	175	2	DOID:1324 (implicated_via_orthology)
Disease	Erythrocytosis familial, 1	HIF1A SH2B3	1.23e-03	9	175	2	C4551637
Disease	Mild cognitive disorder	CACNA1C APP	1.23e-03	9	175	2	C1270972
Disease	Chronic schizophrenia	ACE HSPA9	1.23e-03	9	175	2	C0221765
Disease	level of Phosphatidylcholine (O-18:0_20:4) in blood serum	RAPSN DAGLA	1.23e-03	9	175	2	OBA_2045127
Disease	level of Phosphatidylcholine (16:0_22:4) in blood serum	RAPSN DAGLA	1.23e-03	9	175	2	OBA_2045078
Disease	uterine fibroid	ERBIN HMG20A THRB UGT2A1 ANKRD12 GREB1	1.24e-03	199	175	6	EFO_0000731
Disease	proteinuria (biomarker_via_orthology)	HIF1A ZEB2	1.53e-03	10	175	2	DOID:576 (biomarker_via_orthology)
Disease	C-C motif chemokine 21 measurement	UBA5 ACAD11	1.53e-03	10	175	2	EFO_0008048
Disease	linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement	RAPSN GATAD2A	1.53e-03	10	175	2	EFO_0800499
Disease	stroke	SH2B3 WDFY4 ZNF106 FAT2 SHISA6	1.72e-03	144	175	5	EFO_0000712
Disease	invasive ductal carcinoma (is_marker_for)	VEGFC HIF1A MET	1.72e-03	40	175	3	DOID:3008 (is_marker_for)
Disease	Calcium channel blocker use measurement	CACNA1C SH2B3 ACE CLCN6 PDILT PLCE1	1.76e-03	213	175	6	EFO_0009930
Disease	free androgen index	SIN3A MET SEPHS1 THADA THRB UGT2A1 GREB1 DNMBP	1.83e-03	374	175	8	EFO_0007005
Disease	Leukoencephalopathy	APP CSF1R	1.86e-03	11	175	2	C0270612
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	ACE PKHD1	1.86e-03	11	175	2	DOID:0110861 (biomarker_via_orthology)
Disease	level of Sterol ester (27:1/20:5) in blood serum	RAPSN DAGLA	1.86e-03	11	175	2	OBA_2045197
Disease	Malignant neoplasm of breast	VEGFC HIF1A WWOX ROR1 MCF2L2 SPAG6 ZEB2 SLC2A2 CSF1R PER3 JMJD6 NUP133 TENM1 ROBO1 CPSF3	1.92e-03	1074	175	15	C0006142
Disease	serum alanine aminotransferase measurement	GBF1 RAPSN SH2B3 PCLO SLC2A2 MET CLCN6 RP1L1 SCGB1A1 GRHL3 CARS2 DNMBP PLCE1	2.12e-03	869	175	13	EFO_0004735
Disease	Hematologic Neoplasms	SH2B3 CSF1R	2.22e-03	12	175	2	C0376545
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	RAPSN DAGLA	2.22e-03	12	175	2	OBA_2045157
Disease	cholesteryl ester 20:5 measurement	RAPSN SVIL DAGLA	2.27e-03	44	175	3	EFO_0010349
Disease	glaucoma	RAPSN SH2B3 TXNRD2 PKHD1 PLCE1	2.30e-03	154	175	5	MONDO_0005041
Disease	Squamous cell carcinoma of esophagus	HIF1A WWOX FAT2 PLCE1	2.50e-03	95	175	4	C0279626
Disease	creatinine measurement	KLF8 HIF1A RAPSN STBD1 SIN3A GGT7 RNF123 RRAGD NFE2L1 SVIL PDILT PKHD1 SLC23A2 UNC80	2.53e-03	995	175	14	EFO_0004518
Disease	Hypoxanthine measurement	GPR61 PKHD1	2.61e-03	13	175	2	EFO_0021604
Disease	level of Phosphatidylcholine (O-16:0_20:4) in blood serum	RAPSN DAGLA	2.61e-03	13	175	2	OBA_2045116
Disease	body fat percentage	ANKS1B SLC2A2 RANBP17 GPR61 SPHKAP PDILT PKHD1 UNC79 PLCE1	2.65e-03	488	175	9	EFO_0007800
Disease	myocardial infarction (biomarker_via_orthology)	HIF1A ACE ZEB2 VCAN CACYBP	2.71e-03	160	175	5	DOID:5844 (biomarker_via_orthology)
Disease	Alzheimer disease, polygenic risk score	WWOX PARP8 PLPPR3 ACE SPAG6 HMG20A RNF123 NFE2L1 PKHD1 ROBO1	2.73e-03	586	175	10	EFO_0030082, MONDO_0004975
Disease	systolic blood pressure, alcohol consumption measurement	SH2B3 CLCN6 RP1L1	2.75e-03	47	175	3	EFO_0006335, EFO_0007878
Disease	obsolete_red blood cell distribution width	OGT RAPSN GATAD2A MYO9B SIRPA RNF123 THRA THRB CLCN6 NFE2L1 ATAD2B RP1L1 ANKRD12 PRKCSH SLC23A2 DAGLA KNL1	2.81e-03	1347	175	17	EFO_0005192
Disease	Acute Confusional Senile Dementia	A2M WWOX APP ACE	2.90e-03	99	175	4	C0546126
Disease	Alzheimer's Disease, Focal Onset	A2M WWOX APP ACE	2.90e-03	99	175	4	C0750900
Disease	Alzheimer Disease, Early Onset	A2M WWOX APP ACE	2.90e-03	99	175	4	C0750901
Disease	Presenile dementia	A2M WWOX APP ACE	2.90e-03	99	175	4	C0011265
Disease	Alzheimer Disease, Late Onset	A2M WWOX APP ACE	2.90e-03	99	175	4	C0494463
Disease	serum albumin measurement	VEGFC EXOSC10 RAPSN GATAD2A SH2B3 ASAP3 PRR12 THRB CDK5RAP1 DAGLA	2.93e-03	592	175	10	EFO_0004535
Disease	Familial Alzheimer Disease (FAD)	A2M WWOX APP ACE	3.01e-03	100	175	4	C0276496
Disease	1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement	RAPSN DAGLA	3.04e-03	14	175	2	EFO_0022085
Disease	chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology)	TXNRD2 HIRA	3.04e-03	14	175	2	DOID:0060413 (implicated_via_orthology)
Disease	Impaired cognition	CACNA1C APP	3.04e-03	14	175	2	C0338656
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	RAPSN DAGLA	3.04e-03	14	175	2	OBA_2045100
Disease	level of Phosphatidylethanolamine (18:2_0:0) in blood serum	RAPSN DAGLA	3.04e-03	14	175	2	OBA_2045143
Disease	lysophosphatidylcholine 22:5 measurement	RAPSN DAGLA	3.04e-03	14	175	2	EFO_0021462
Disease	Alzheimer's Disease	A2M WWOX APP ACE	3.12e-03	101	175	4	C0002395
Disease	Weight Gain	SORBS2 APP ACE RYK	3.23e-03	102	175	4	C0043094
Disease	Diuretic use measurement	SH2B3 ZEB2 CREB3L1 CLCN6 PDILT	3.43e-03	169	175	5	EFO_0009928
Disease	refractive error	A2M GATAD2A NBEA CYRIA THRB DAGLA SHISA6	3.43e-03	326	175	7	MONDO_0004892
Disease	phosphatidylcholine 36:3 measurement	RAPSN TMEM132D	3.49e-03	15	175	2	EFO_0010381
Disease	response to olanzapine	CACNA1C ANKS1B	3.49e-03	15	175	2	GO_0097333
Disease	intraocular pressure measurement	VEGFC EXOSC10 RAPSN SH2B3 PCLO TXNRD2 ZNF106 THADA PKHD1	3.49e-03	509	175	9	EFO_0004695
Disease	mean arterial pressure, alcohol consumption measurement	SH2B3 CLCN6 RP1L1	3.66e-03	52	175	3	EFO_0006340, EFO_0007878
Disease	level of triacylglycerol (56:6) in blood serum	RAPSN GATAD2A	3.97e-03	16	175	2	OBA_2020007
Disease	vitamin C measurement	RAPSN SLC23A2	3.97e-03	16	175	2	EFO_0600003
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	ACE PKHD1	3.97e-03	16	175	2	DOID:0110861 (implicated_via_orthology)
Disease	Agents acting on the renin-angiotensin system use measurement	CACNA1C SH2B3 MYO9B CLCN6 PDILT PKHD1 PLCE1	3.98e-03	335	175	7	EFO_0009931
Disease	Mammary Carcinoma, Human	VEGFC HIF1A WWOX ROR1 ZEB2 SLC2A2 CSF1R PER3 JMJD6	4.27e-03	525	175	9	C4704874
Disease	Mammary Neoplasms, Human	VEGFC HIF1A WWOX ROR1 ZEB2 SLC2A2 CSF1R PER3 JMJD6	4.27e-03	525	175	9	C1257931
Disease	HOMA-B	RAPSN SLC2A2 ARHGEF10	4.29e-03	55	175	3	EFO_0004469
Disease	Mammary Neoplasms	VEGFC HIF1A WWOX ROR1 ZEB2 SLC2A2 CSF1R PER3 JMJD6	4.37e-03	527	175	9	C1458155
Disease	Benign neoplasm of stomach	POLE MET	4.49e-03	17	175	2	C0153943
Disease	Dementia	APP CSF1R	4.49e-03	17	175	2	C0497327
Disease	Vitiligo	SH2B3 IKZF4	4.49e-03	17	175	2	C0042900
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	SIRPA SVIL	4.49e-03	17	175	2	EFO_0010543, EFO_0010544

Protein segments in the cluster

Peptide	Gene	Start	Entry
MDYGEELRSPITSLT	SYT11	126	Q9BT88
SSNREYETLAMPEGS	TTF1	226	Q15361
EIPERTMSVSDFNYS	ERBIN	1151	Q96RT1
EQEASPDRTTLYSLM	ARHGEF10	546	O15013
EMYLPVRFSSESTRS	ASAP3	841	Q8TDY4
TASQMPSRSLLFYDD	CREB3L1	416	Q96BA8
RYLVTFSPLMDTQDD	EIF3B	386	P55884
RTETLIPEMRTDTYT	VCAN	686	P13611
PSNDMYADTVTTVIL	CPSF3	571	Q9UKF6
RSMYETPSLEQDLER	ACE	826	P12821
ISYGNDALMPSLTET	APP	586	P05067
ALTDTYSRITVPENM	ADGRG4	1736	Q8IZF6
TSLPMSINVTDDIVY	ADGRG4	2086	Q8IZF6
SYMEEPSQRDDISRL	DYNLT5	46	Q8N7M0
LPSYMLQSEELRASL	DNMBP	1266	Q6XZF7
LESYMGIRDPELAST	GIPC3	251	Q8TF64
SALTITVNPMETYED	CLSTN1	906	O94985
SSEMSLQPDLVRYDN	ANKRD12	571	Q6UB98
LSEPDLASYSVVMVD	DHX16	506	O60231
MDLELSLTSTYTNTP	ATG2B	431	Q96BY7
YSENSGIPSMEELIS	ACAD11	276	Q709F0
APSAEVEMTSYVLLA	A2M	1201	P01023
MEVNTSASEILYSAP	NFE2L1	326	Q14494
ELTQEMNLVDYSRPS	RANBP17	156	Q9H2T7
VDSADQMLTSYPSER	PGBD4	431	Q96DM1
DLETAFPRYDSAMSI	RAPSN	261	Q13702
SYMELLVSIALDPDT	QSER1	1551	Q2KHR3
QELYTDSPMESTQSL	RAB11FIP4	151	Q86YS3
MAPYSSVSLVEQLED	FAM81A	21	Q8TBF8
EEIMTCTDYIPRSSN	EYA3	51	Q99504
SESLSDPSQLNLYMR	MAMDC2	91	Q7Z304
DTEQSYVESLRTLMQ	ARHGEF17	1076	Q96PE2
RNYTMEIVPSASLDT	ANKS1B	431	Q7Z6G8
DPMASRNVIATETSY	DSG2	926	Q14126
SSSAVDRQREYLLDM	GATAD2A	606	Q86YP4
EDMASTRYESLLENL	C22orf15	86	Q8WYQ4
ELRDVSPYMDTSSTT	MUC16	4016	Q8WXI7
VTQISVDLMDDYPAS	NUP133	561	Q8WUM0
TPEYRSRFTSEETLM	CYRIA	236	Q9H0Q0
SITSIREMTQAPYLE	PARP8	611	Q8N3A8
SESSYDIDNIVIPMS	KANSL1L	766	A0AUZ9
MESTRDDSPLYIFDS	JMJD6	121	Q6NYC1
TSDIIMSDSYLRPAA	GPR61	431	Q9BZJ8
VESMLDSLELEPTYN	M1AP	426	Q8TC57
NLLDLVVTEMYDTPT	NCR1	111	O76036
PLLRYDSSFEAMVTA	GREB1	871	Q4ZG55
ETPTVDTIDSYMNRL	HMG20A	306	Q9NP66
IDDLTTLGTSEPYRM	MTO1	476	Q9Y2Z2
VTSTTEPSRCEYLME	PRKCSH	491	P14314
STQDTDLDLEMLAPY	HIF1A	551	Q16665
EEYLRLSAVPTSMGD	KATNIP	696	O60303
SVDDSLVYRMIPSTS	LRFN1	461	Q9P244
LLSTSETMYSELPEE	ATAD2B	866	Q9ULI0
LSLLESRMEVDDYSQ	KMT5B	806	Q4FZB7
PDEDFLNVMTYLTSI	MCF2L2	76	Q86YR7
RDYMSDSEVSSTRPT	PCLO	3831	Q9Y6V0
PQADVSMYSLEELAT	PER3	106	P56645
LVSAMSPSEVTYELR	FAT2	1681	Q9NYQ8
RLGDPVYDSTITESM	GGT7	421	Q9UJ14
YDTETDPSEGLMNVL	CACYBP	181	Q9HB71
LLVASEDSSYMPARV	CUL7	891	Q14999
INSTDELPTISYSMN	SLC2A2	61	P11168
EYRSNMTSPTLLDAN	KLF8	41	O95600
DARILAMTPESIYSN	KNL1	431	Q8NG31
DPRSTMLAYDASSIQ	GABRB2	426	P47870
QVRASPSSMDVYDSL	KIAA1549L	371	Q6ZVL6
QAPYDSSAIEMTLVE	POLE	2191	Q07864
LDSTDPSNLSLMAYA	NLRX1	411	Q86UT6
SSVQTDINLPYLTMD	HSPA9	321	P38646
EASDDYPMSREELLS	ODAD1	471	Q96M63
SPSLETGSRQSDYME	GORASP1	241	Q9BQQ3
SELLYMLESPESLRS	PABPC3	586	Q9H361
VLPMEYENNSTLSET	PTPRO	316	Q16827
PVGSYESSEMNSIDI	CCSER2	526	Q9H7U1
SLAREVSLDYERSMN	DNAH1	436	Q9P2D7
YRLSSSEGNPVDDME	DNAH1	3396	Q9P2D7
DTLELRSDMYILNES	EXOSC10	341	Q01780
RSDMYILNESLTDPA	EXOSC10	346	Q01780
DEPSAYLDSEQRLMA	ABCE1	486	P61221
SASQPRLSYAEMAED	CLCN6	766	P51797
DTYVEMRPVSTSSND	CSF1R	721	P07333
SSVASPEDVQALMYL	HDAC10	636	Q969S8
LLPSNDMISFSIDRY	IGSF10	2176	Q6WRI0
EAGSVDSYLLPTTDM	GRHL3	156	Q8TE85
LDPDMYSLLEDSTSD	GPN3	191	Q9UHW5
CSEPSLLSTEMLSYQ	CACNA1C	1931	Q13936
MSSRFLPYDNIITDA	EXT1	546	Q16394
METSSRELQAAEYLE	EFCAB10	1	A6NFE3
RETYTFENSVNMLPS	CENPC	181	Q03188
DMLISSQPVLSSLEY	C1orf226	136	A1L170
LSMTRPVSIEGSEEY	INTS14	11	Q96SY0
AFPNEYTRMSTSELI	CLCN5	441	P51795
YATMLPDSTEIDQDT	COL6A2	216	P12110
TMVVENFPDSSDLYS	FHOD3	1131	Q2V2M9
PESYTTEATRRMNDI	BLMH	166	Q13867
PLATMESLSDTESLY	DAGLA	776	Q9Y4D2
RVPTASYDLDLFTMT	GBF1	916	Q92538
AFTLQVSSDPSMYIE	HIRA	691	P54198
YSLPRETVSMDLESE	CREB3	81	O43889
IATDSTPVDMQTYEL	RRAGD	271	Q9NQL2
ITDNALSRDLFPMDY	RYK	481	P34925
LRTLTTMAPYLSTED	IPO4	181	Q8TEX9
MNYTESSPLRESTAI	BVES	1	Q8NE79
VEMYSDEESSRLLGP	IKZF4	101	Q9H2S9
ALFMDYIITDQETSP	OGT	671	O15294
ISSSNLYPREDMEAV	PSG3	151	Q16557
MEYSSDADFIESLPL	NAP1L6P	31	A6NFF2
MYLSLENNSISSIPE	OMD	236	Q99983
MRDVTISKSEYAPSE	PHYH	101	O14832
LTFLNRAEDYTLTMP	OSBPL5	521	Q9H0X9
SMSDPGVSYRTREEI	PDHA2	291	P29803
LSSDARYKMPSDDIT	PDILT	341	Q8N807
PTTEMVSNESVDYRA	MET	991	P08581
LLSVPSNLESSRMYD	SPHKAP	6	Q2M3C7
SNLESSRMYDVLEPQ	SPHKAP	11	Q2M3C7
EMNISPASLASLYEE	CARS2	131	Q9HA77
VLERLYASPMDGTSS	THADA	1326	Q6YHU6
PVLLSLYMSTESSED	SPAG6	381	O75602
TQTERDIPMSDSLYR	RHEX	71	Q6ZWK4
TMEDLTPALSEYGIN	TAF10	196	Q12962
LLDQYLSMTDPSRAQ	PPP4R1	621	Q8TF05
EEDTPRYMRASDPAS	SVIL	36	O95425
DDEYPTRNSIVMSSE	TMEM132D	1056	Q14C87
DDMTDSLRDYTNLPE	NXN	376	Q6DKJ4
RDLDSMDPAVYSLTI	PLCE1	1861	Q9P212
PDMYDTNTSLSTSRD	TAF1L	1666	Q8IZX4
EYLTMSLPEVSFADS	NBEAL2	661	Q6ZNJ1
TDYPVSTDTRDLLMS	NBEA	1016	Q8NFP9
EDFRMATLYSRTQTP	PTGDS	141	P41222
SSYLLSEDMLNDPNL	SCN9A	671	Q15858
MSTRESFNPESYELD	SEPHS1	1	P49903
YVERYMNSDTTSPEL	SIN3A	1101	Q96ST3
GSIDPTQYEDTLREM	SIN3B	861	O75182
QPASEDTLTYADLDM	SIRPA	461	P78324
MNNILTSATEPYDLS	SHISA6	271	Q6ZSJ9
LAMDPVSESLYLSDT	TENM1	1241	Q9UKZ4
TPEVSYDLTMTDSRN	PKHD1	2581	P08F94
RSYVEMLVSTALDPD	PRR12	1851	Q9ULL5
PTLTEEEISAMYSSV	PAG1	306	Q9NWQ8
TDLMQDTSRLLDPYI	OSM	46	P13725
LYQSSIDRSLERPMS	SORBS2	231	O94875
TPLESRLGYMSASEQ	CEP164	1376	Q9UPV0
DMVPAISLAYESAES	ATP1A4	821	Q13733
MEYLSALNPSDLLRS	CIDEB	1	Q9UHD4
NVLLSLDETYADVMP	CDK5RAP1	226	Q96SZ6
LDETYADVMPVQTSA	CDK5RAP1	231	Q96SZ6
SYLTLDEPMNNITTS	ROR1	56	Q01973
RSIFEMYEPSELESS	SUPT6H	266	Q7KZ85
IETLLMDTPSSYEAA	SCGB1A1	31	P11684
RSVSSVDELMTVLYP	VEGFC	61	P49767
LNLEVPTYEFTSDDM	UQCRFS1	256	P47985
SISMPSVVSEQEAYL	UNC80	2976	Q8N2C7
AETQMPSYSLSLGEE	TEP1	201	Q99973
ASVQSMPDTEESRLY	TIAM1	121	Q13009
SYSEVSRNESLESPM	STBD1	136	O95210
MQEYPDEQTSRTLTL	SYNGAP1	611	Q96PV0
TRMYPESSTSEQEEA	RP1L1	2341	Q8IWN7
SLDPQRSDMIYTIED	SLC23A2	81	Q9UGH3
DRTLSMPYVETNEEL	PLPPR3	56	Q6T4P5
EKMSSEVVDSNPYSR	UBA5	41	Q9GZZ9
SMEELPGYEETLTRL	RNF123	886	Q5XPI4
SSYSSEERFMEIESP	SYCP2	1221	Q9BX26
YDPESETLTLNGEMA	THRB	321	P10828
ERMLTATESRLDYPD	TMEM79	366	Q9BSE2
YGDRMDLSSITDPLI	WDFY4	2781	Q6ZS81
TDRDMECLSQYPSLS	PRAMEF10	306	O60809
PTTRQRYDGSTTAME	WWOX	101	Q9NZC7
PVNRARDSDYEMDSS	SH2B3	546	Q9UQQ2
MLPESTVYGDVDLSN	ROBO1	1031	Q9Y6N7
QLQTRSADEPMTTFY	POLR3K	81	Q9Y2Y1
MDSISDSRLYESNPV	ZC3H12B	701	Q5HYM0
SSDLMDYDNVPTTVF	TXNRD2	386	Q9NNW7
AAYEVLVMLADSSPS	USP24	1636	Q9UPU5
QEELPMYSLSSSDEA	UEVLD	136	Q8IX04
MQTEGPELEERYSTL	ZSWIM3	631	Q96MP5
SYQELLQSASASPMD	XPO7	471	Q9UIA9
TLPLSNYMLSREDSQ	USP17L7	101	P0C7H9
RYDPESDTLTLSGEM	THRA	266	P10827
PLMDALSESSLYSRS	TARBP1	421	Q13395
ITPQGYSDSEERESM	ZEB2	1116	O60315
TLDSPTMEAYVTETA	RIPOR1	1051	Q6ZS17
SYVPAVLSELTDQMS	UGT2A1	191	P0DTE4
SESSVIMDRAPSVYS	ZNF106	861	Q9H2Y7
LNDDILSTLPYTMIS	UNC79	166	Q9P2D8
SDSSYVRELIGMDPV	MYO9B	666	Q13459